Prevalence of Mtb Infection during pregnancy measured by TST or IGRA.

Saved in:

Bibliographic Details
Main Author:	Alison J. Morton (20314788) (author)
Other Authors:	Alexandra Roddy Mitchell (20314791) (author), Richard E. Melville (20314794) (author), Lisa Hui (524198) (author), Steven Y. C. Tong (6849431) (author), Sarah J. Dunstan (20314797) (author), Justin T. Denholm (5710625) (author)
Published:	2024
Subjects:	Medicine Cell Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Biological Sciences not elsewhere classified synthesise published literature serious adverse events searched ovid medline tuberculin skin test 19 – 0 0 – 100 mycobacterium tuberculosis </ tpt appears safe div >< p completing antenatal tst cochrane central register 47 studies met 4 %- 96 3 – 1 mycobacterium tuberculosis infection high screening adherence tb preventative treatment active tb disease developing tuberculosis test performance mtb </ irr 1 targeted screening october 3 infection screening 3 %, high tb study aims significant association release assay rates increasing optimise algorithms natural history maternal age make evidence interferon gamma informed decisions increased age inclusion criteria incidence settings four studies ensuring pregnant controlled trials chest radiograph
Tags:	Add Tag No Tags, Be the first to tag this record!

_version_	1852024969944367104
author	Alison J. Morton (20314788)
author2	Alexandra Roddy Mitchell (20314791) Richard E. Melville (20314794) Lisa Hui (524198) Steven Y. C. Tong (6849431) Sarah J. Dunstan (20314797) Justin T. Denholm (5710625)
author2_role	author author author author author author
author_facet	Alison J. Morton (20314788) Alexandra Roddy Mitchell (20314791) Richard E. Melville (20314794) Lisa Hui (524198) Steven Y. C. Tong (6849431) Sarah J. Dunstan (20314797) Justin T. Denholm (5710625)
author_role	author
dc.creator.none.fl_str_mv	Alison J. Morton (20314788) Alexandra Roddy Mitchell (20314791) Richard E. Melville (20314794) Lisa Hui (524198) Steven Y. C. Tong (6849431) Sarah J. Dunstan (20314797) Justin T. Denholm (5710625)
dc.date.none.fl_str_mv	2024-11-22T18:30:42Z
dc.identifier.none.fl_str_mv	10.1371/journal.pgph.0003578.t001
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Prevalence_of_i_Mtb_i_Infection_during_pregnancy_measured_by_TST_or_IGRA_/27892191
dc.rights.none.fl_str_mv	CC BY 4.0 info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Medicine Cell Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Biological Sciences not elsewhere classified synthesise published literature serious adverse events searched ovid medline tuberculin skin test 19 – 0 0 – 100 mycobacterium tuberculosis </ tpt appears safe div >< p completing antenatal tst cochrane central register 47 studies met 4 %- 96 3 – 1 mycobacterium tuberculosis infection high screening adherence tb preventative treatment active tb disease developing tuberculosis test performance mtb </ irr 1 targeted screening october 3 infection screening 3 %, high tb study aims significant association release assay rates increasing optimise algorithms natural history maternal age make evidence interferon gamma informed decisions increased age inclusion criteria incidence settings four studies ensuring pregnant controlled trials chest radiograph
dc.title.none.fl_str_mv	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.</p>
eu_rights_str_mv	openAccess
id	Manara_b3aaa947e3bdd9a0c3eaece7be2040fa
identifier_str_mv	10.1371/journal.pgph.0003578.t001
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/27892191
publishDate	2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY 4.0
spelling	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.Alison J. Morton (20314788)Alexandra Roddy Mitchell (20314791)Richard E. Melville (20314794)Lisa Hui (524198)Steven Y. C. Tong (6849431)Sarah J. Dunstan (20314797)Justin T. Denholm (5710625)MedicineCell BiologyBiotechnologyImmunologyCancerScience PolicyInfectious DiseasesBiological Sciences not elsewhere classifiedsynthesise published literatureserious adverse eventssearched ovid medlinetuberculin skin test19 – 00 – 100mycobacterium tuberculosis </tpt appears safediv >< pcompleting antenatal tstcochrane central register47 studies met4 %- 963 – 1mycobacterium tuberculosis infectionhigh screening adherencetb preventative treatmentactive tb diseasedeveloping tuberculosistest performancemtb </irr 1targeted screeningoctober 3infection screening3 %,high tbstudy aimssignificant associationrelease assayrates increasingoptimise algorithmsnatural historymaternal agemake evidenceinterferon gammainformed decisionsincreased ageinclusion criteriaincidence settingsfour studiesensuring pregnantcontrolled trialschest radiograph<p>Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.</p>2024-11-22T18:30:42ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pgph.0003578.t001https://figshare.com/articles/dataset/Prevalence_of_i_Mtb_i_Infection_during_pregnancy_measured_by_TST_or_IGRA_/27892191CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/278921912024-11-22T18:30:42Z
spellingShingle	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA. Alison J. Morton (20314788) Medicine Cell Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Biological Sciences not elsewhere classified synthesise published literature serious adverse events searched ovid medline tuberculin skin test 19 – 0 0 – 100 mycobacterium tuberculosis </ tpt appears safe div >< p completing antenatal tst cochrane central register 47 studies met 4 %- 96 3 – 1 mycobacterium tuberculosis infection high screening adherence tb preventative treatment active tb disease developing tuberculosis test performance mtb </ irr 1 targeted screening october 3 infection screening 3 %, high tb study aims significant association release assay rates increasing optimise algorithms natural history maternal age make evidence interferon gamma informed decisions increased age inclusion criteria incidence settings four studies ensuring pregnant controlled trials chest radiograph
status_str	publishedVersion
title	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
title_full	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
title_fullStr	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
title_full_unstemmed	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
title_short	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
title_sort	Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.
topic	Medicine Cell Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Biological Sciences not elsewhere classified synthesise published literature serious adverse events searched ovid medline tuberculin skin test 19 – 0 0 – 100 mycobacterium tuberculosis </ tpt appears safe div >< p completing antenatal tst cochrane central register 47 studies met 4 %- 96 3 – 1 mycobacterium tuberculosis infection high screening adherence tb preventative treatment active tb disease developing tuberculosis test performance mtb </ irr 1 targeted screening october 3 infection screening 3 %, high tb study aims significant association release assay rates increasing optimise algorithms natural history maternal age make evidence interferon gamma informed decisions increased age inclusion criteria incidence settings four studies ensuring pregnant controlled trials chest radiograph

Prevalence of <i>Mtb</i> Infection during pregnancy measured by TST or IGRA.

Similar Items